Settlement Efforts Continue in Roundup Cancer Litigation

roundup cancer
Despite facing more than 100,000 Roundup cancer claims, attorneys representing the weed killer manufacturer’s parent company claim that they are making progress in their settlement negotiations. A recent video call between attorneys from both sides and the federal judge overseeing their case resulted in the continuation of an ongoing stay in the case.

Roundup cancer victims claim that the popular herbicide caused their non-Hodgkins lymphoma. According to Monsanto owner Bayer AG’s attorneys, some of their efforts to resolve legal claims have been successful, yet they still have a long way to go. The latest update from the chemical giant’s attorney added more than 3,000 lawsuits that he said are close to reaching deals, while thousands of others have already been resolved. The group of plaintiffs that are in the latest RoundUp negotiation represents those whose claims were filed as part of multidistrict litigation filed in the U.S District Court for the Northern District of California.

Roundup Cancer Victims’ Attorneys Claim Company is Reneging on Earlier Agreements

While Bayer AG attorney William Hoffman has indicated progress, attorneys representing Roundup cancer victims are accusing the company of having reneged on the terms of agreements that had earlier been negotiated. Other victims are rejecting offers that they view as insufficient. At this point, U.S. District Judge Vince Chhabria has chosen to allow the talks to continue, based on Mr. Hoffman’s assertions that they are “hopefully going to finalize additional agreements in the next several days.” An attorney representing many of the plaintiffs, Brent Wisner, echoed Hoffman’s comments, pointing out nearly 2,000 cases are in discussion and that he anticipates those resolutions shortly.

Based on these assurances, Judge Chhabria has chosen to continue the stay that is currently in place in the Roundup cancer cases until November 2nd. Any cases that have not resolved by that date, however, will be moved to trial.

Author: Terri Oppenheimer

Terri Oppenheimer

Terri Oppenheimer is an independent writer, editor, and proofreader. She graduated from the College of William and Mary with a degree in English. She specializes in providing content for websites and finds tremendous enjoyment in the things she learns while doing her research. Her specific areas of interest include health and fitness, medical research, and the law.